Log in to save to my catalogue

Q151M-Mediated Multinucleoside Resistance: Prevalence, Risk Factors, and Response to Salvage Therapy

Q151M-Mediated Multinucleoside Resistance: Prevalence, Risk Factors, and Response to Salvage Therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_80099187

Q151M-Mediated Multinucleoside Resistance: Prevalence, Risk Factors, and Response to Salvage Therapy

About this item

Full title

Q151M-Mediated Multinucleoside Resistance: Prevalence, Risk Factors, and Response to Salvage Therapy

Publisher

Chicago, IL: The University of Chicago Press

Journal title

Clinical infectious diseases, 2004-02, Vol.38 (3), p.433-437

Language

English

Formats

Publication information

Publisher

Chicago, IL: The University of Chicago Press

More information

Scope and Contents

Contents

Among 470 patients with acquired immune deficiency syndrome and/or human immunodeficiency virus infection (HIV/AIDS) who underwent genotype resistance testing (GRT) after the failure of therapy, 17 (3.6%) harbored the Q151M mutation. The Q151M mutation was associated with younger age, lower CD4+ lymphocyte count, higher HIV RNA level, and treatment...

Alternative Titles

Full title

Q151M-Mediated Multinucleoside Resistance: Prevalence, Risk Factors, and Response to Salvage Therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_80099187

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_80099187

Other Identifiers

ISSN

1058-4838,1537-6591

E-ISSN

1537-6591

DOI

10.1086/381097

How to access this item